Akamai Technologies (AKAM) Holder Connor Clark & Lunn Investment Management LTD Trimmed Its Holding; M&T Bank Increases Holding in Abbvie (ABBV)

January 20, 2018 - By Winifred Garcia

Connor Clark & Lunn Investment Management Ltd decreased its stake in Akamai Technologies Inc (AKAM) by 88.11% based on its latest 2017Q3 regulatory filing with the SEC. Connor Clark & Lunn Investment Management Ltd sold 180,025 shares as the company’s stock declined 24.00% while stock markets rallied. The institutional investor held 24,300 shares of the miscellaneous company at the end of 2017Q3, valued at $1.18 million, down from 204,325 at the end of the previous reported quarter. Connor Clark & Lunn Investment Management Ltd who had been investing in Akamai Technologies Inc for a number of months, seems to be less bullish one the $11.10B market cap company. The stock increased 0.85% or $0.55 during the last trading session, reaching $65.63. About 1.37 million shares traded. Akamai Technologies, Inc. (NASDAQ:AKAM) has declined 6.51% since January 20, 2017 and is downtrending. It has underperformed by 23.21% the S&P500.

M&T Bank Corp increased its stake in Abbvie Inc (ABBV) by 6216780.95% based on its latest 2017Q3 regulatory filing with the SEC. M&T Bank Corp bought 1.31 million shares as the company’s stock rose 6.17% with the market. The institutional investor held 1.31 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $116.01 million, up from 21 at the end of the previous reported quarter. M&T Bank Corp who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $167.05 billion market cap company. The stock increased 0.80% or $0.83 during the last trading session, reaching $104.64. About 4.99 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 20, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

M&T Bank Corp, which manages about $18.43B US Long portfolio, decreased its stake in Middleby Corp (NASDAQ:MIDD) by 4,169 shares to 13,238 shares, valued at $1.70 million in 2017Q3, according to the filing. It also reduced its holding in Powershares Etf Trust Ii (BKLN) by 27,447 shares in the quarter, leaving it with 30,704 shares, and cut its stake in Ishares Tr (TIP).

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 71 analyst reports since July 21, 2015 according to SRatingsIntel. On Friday, July 28 the stock rating was maintained by Cowen & Co with “Hold”. Jefferies maintained AbbVie Inc. (NYSE:ABBV) on Monday, June 26 with “Buy” rating. As per Tuesday, March 15, the company rating was initiated by Deutsche Bank. Jefferies upgraded it to “Buy” rating and $55 target in Monday, December 7 report. The firm has “Buy” rating by Jefferies given on Monday, July 17. Jefferies maintained AbbVie Inc. (NYSE:ABBV) on Tuesday, January 16 with “Buy” rating. On Wednesday, April 19 the stock rating was maintained by BMO Capital Markets with “Hold”. The rating was maintained by Cowen & Co on Tuesday, September 5 with “Hold”. On Friday, June 10 the stock rating was downgraded by BMO Capital Markets to “Market Perform”. Leerink Swann upgraded the shares of ABBV in report on Monday, October 2 to “Outperform” rating.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.15, from 1 in 2017Q2. It fall, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Andra Ap invested in 87,500 shares. Mirador Capital Ptnrs Limited Partnership stated it has 1.02% of its portfolio in AbbVie Inc. (NYSE:ABBV). Becker Cap Mgmt invested in 0.02% or 7,184 shares. Iguana Mgmt Llc holds 3.22% or 65,000 shares. Highland Capital Mgmt Llc holds 24,979 shares. Moreover, Alpine Woods Cap Invsts Limited Liability has 0.14% invested in AbbVie Inc. (NYSE:ABBV) for 31,783 shares. Wagner Bowman Mngmt Corp reported 0.38% in AbbVie Inc. (NYSE:ABBV). Warren Averett Asset Limited Company invested 0.19% in AbbVie Inc. (NYSE:ABBV). Great Lakes Advisors Limited Liability Com holds 0.96% or 458,527 shares. Guggenheim Cap Ltd, Illinois-based fund reported 1.64 million shares. Strategic Financial Service has 5,122 shares for 0.08% of their portfolio. Northwest Investment Counselors Lc holds 0.33% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 8,474 shares. Amer National Registered Invest Advisor Incorporated has 12,601 shares for 0.56% of their portfolio. Mogy Joel R Counsel reported 72,041 shares. Cypress Asset Mgmt Incorporated Tx owns 20,583 shares or 0.39% of their US portfolio.

Since July 31, 2017, it had 0 buys, and 8 selling transactions for $45.57 million activity. Gosebruch Henry O had sold 300 shares worth $21,127 on Monday, July 31. On Monday, December 18 RICHMOND TIMOTHY J. sold $8.57 million worth of AbbVie Inc. (NYSE:ABBV) or 87,040 shares. Another trade for 8,300 shares valued at $705,655 was made by SALEKI-GERHARDT AZITA on Monday, September 11. Schumacher Laura J also sold $14.07 million worth of AbbVie Inc. (NYSE:ABBV) shares. On Thursday, September 28 Michael Robert A. sold $589,512 worth of AbbVie Inc. (NYSE:ABBV) or 6,699 shares.

Connor Clark & Lunn Investment Management Ltd, which manages about $26.75 billion and $16.66B US Long portfolio, upped its stake in Lear Corp (NYSE:LEA) by 89,800 shares to 95,200 shares, valued at $16.48 million in 2017Q3, according to the filing. It also increased its holding in Celgene Corp (NASDAQ:CELG) by 105,750 shares in the quarter, for a total of 157,193 shares, and has risen its stake in Pier 1 Imports Inc/De (NYSE:PIR).

Investors sentiment increased to 0.99 in 2017 Q3. Its up 0.24, from 0.75 in 2017Q2. It improved, as 51 investors sold AKAM shares while 138 reduced holdings. 38 funds opened positions while 150 raised stakes. 138.17 million shares or 0.41% less from 138.74 million shares in 2017Q2 were reported. Parallax Volatility Advisers Ltd Partnership has 0% invested in Akamai Technologies, Inc. (NASDAQ:AKAM) for 18,086 shares. The New York-based Oppenheimer And Co has invested 0.15% in Akamai Technologies, Inc. (NASDAQ:AKAM). Shine Inv Advisory Service Inc invested in 353 shares or 0.01% of the stock. 9,158 were accumulated by Woodstock. Kentucky Retirement Insurance Fund has invested 0.04% of its portfolio in Akamai Technologies, Inc. (NASDAQ:AKAM). Soros Fund Management Ltd Company has 7,900 shares for 0.01% of their portfolio. Parsons Capital Mgmt Inc Ri, a Rhode Island-based fund reported 5,000 shares. The Pennsylvania-based Pnc Finance Services has invested 0% in Akamai Technologies, Inc. (NASDAQ:AKAM). The Korea-based Natl Pension Ser has invested 0.05% in Akamai Technologies, Inc. (NASDAQ:AKAM). Guggenheim Cap invested in 1.38 million shares. Cibc Asset Inc reported 26,166 shares or 0.01% of all its holdings. Moreover, Earnest Prtnrs has 0.36% invested in Akamai Technologies, Inc. (NASDAQ:AKAM) for 737,501 shares. Moreover, Barclays Public Limited has 0.01% invested in Akamai Technologies, Inc. (NASDAQ:AKAM) for 185,046 shares. Gulf Intll Natl Bank (Uk) Ltd owns 0.04% invested in Akamai Technologies, Inc. (NASDAQ:AKAM) for 53,958 shares. First Mercantile Tru Co holds 0.12% or 13,251 shares in its portfolio.

Among 29 analysts covering Akamai Tech (NASDAQ:AKAM), 14 have Buy rating, 3 Sell and 12 Hold. Therefore 48% are positive. Akamai Tech had 80 analyst reports since July 29, 2015 according to SRatingsIntel. RBC Capital Markets maintained Akamai Technologies, Inc. (NASDAQ:AKAM) on Sunday, October 8 with “Hold” rating. On Wednesday, February 10 the stock rating was maintained by FBR Capital with “Underperform”. Wells Fargo maintained Akamai Technologies, Inc. (NASDAQ:AKAM) on Wednesday, October 25 with “Market Perform” rating. Craig Hallum downgraded the shares of AKAM in report on Wednesday, April 27 to “Hold” rating. The company was maintained on Thursday, July 30 by M Partners. As per Friday, November 20, the company rating was downgraded by Goldman Sachs. The rating was maintained by FBR Capital with “Underperform” on Thursday, April 28. The rating was maintained by Morgan Stanley with “Underweight” on Wednesday, July 26. On Friday, August 28 the stock rating was upgraded by JMP Securities to “Market Outperform”. RBC Capital Markets initiated the shares of AKAM in report on Thursday, March 24 with “Sector Perform” rating.

Analysts await Akamai Technologies, Inc. (NASDAQ:AKAM) to report earnings on February, 6. They expect $0.45 EPS, down 18.18% or $0.10 from last year’s $0.55 per share. AKAM’s profit will be $76.12M for 36.46 P/E if the $0.45 EPS becomes a reality. After $0.41 actual EPS reported by Akamai Technologies, Inc. for the previous quarter, Wall Street now forecasts 9.76% EPS growth.

Since October 2, 2017, it had 1 insider buy, and 5 sales for $3.86 million activity. Wheaton William sold $662,900 worth of stock. 17,537 Akamai Technologies, Inc. (NASDAQ:AKAM) shares with value of $999,784 were bought by LEIGHTON F THOMSON.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: